Most Recent
Generic Health has shaved two percent off the $25 million damages awarded pharmaceutical giant Bayer in a patent infringement case over Bayer's blockbuster oral contraceptive, Yasmin, but the discount is a far cry from the 15 percent it sought on appeal.
Generic drug maker Alphapharm has lost another bid for documents from Sanofi-Aventis in advance of a hearing on Sanofi's interlocutory application seeking to block the generic drug maker from listing its injector pen on the Pharmaceutical Benefits Scheme.
Wyeth must pay a group of generic drug companies for the harm they suffered after the drug maker won interlocutory injunctions blocking their plans to market an extended release generic version of anti-depressant Effexor, in a ruling likely to have a chilling effect on interlocutory injunction grants in pharmaceutical patent cases.
A group representing patent and trade mark lawyers is seeking to intervene in a high-stakes appeal over computer software patents.
US seafood giant Trident Seafoods has filed an appeal over a trade mark registration by Australian rival Trident Foods, which will be heard by the Full Federal Court.
Swedish air conditioner supplier Dometic has lost is case alleging patent infringement claims against Australian rivals Houghton Leisure and Finch Australia over the popular Belaire 3200 AC used in caravans and other recreational vehicles.
Domino's Pizza and Precision Tracking have reached a settlement on the eve of trial in a hard-fought battle by the US pizza giant to invalidate two of the Australian tech startup's patents covering a GPS system that helps customers locate delivery drivers in real-time.
Generic drug company Apotex has settled a patent infringement case brought by global pharmaceutical giant Lundbeck over its blockbuster antidepressant Lexapro.
The Commonwealth of Australia has resolved its claims against pharmaceutical giant Wyeth over the price it paid to list Effexor on the PBS, months after a high stakes trial wrapped up.
Motorola has slammed an attempt by Hytera Communications to limit discovery in a long-running patent dispute between the companies, saying documents withheld by the Shenzen-based radio manufacturer come nowhere close to being state secrets protected under Chinese law.